Huichun Liang
Kunming, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Corrigendum to "PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer" [Cancer Lett. 598 (2024) 217112].
Journal: Cancer letters
Published: June 30, 2026
STAMBPL1 activates the GRHL3/HIF1A/VEGFA axis through interaction with FOXO1 to promote angiogenesis in triple-negative breast cancer.
Journal: eLife
Published: April 10, 2025
Antenna effect-modulated luminescent lanthanide complexes for biological sensing.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: February 20, 2025
A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth.
Journal: Signal transduction and targeted therapy
Published: January 22, 2025
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer.
Journal: Cancer letters
Published: March 13, 2024
CDK9 targeting PROTAC L055 inhibits ERα-positive breast cancer.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 12, 2024
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4.
Journal: Acta biochimica et biophysica Sinica
Published: May 10, 2023
Targeting HECTD3-IKKα axis inhibits inflammation-related metastasis.
Journal: Signal transduction and targeted therapy
Published: September 23, 2021
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.
Journal: International journal of biological sciences
Published: July 25, 2021
Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis.
Journal: International journal of biological sciences
Published: August 20, 2019
Last Updated: 09/26/2026